US clinical-stage biotech Arcus Biosciences has entered into a clinical trial collaboration with AstraZeneca on renal cancer ...

"Arcus and AstraZeneca enter trial collaboration for renal cancer treatment" was originally created and published by Clinical ...

Wednesday announced a clinical trial collaboration agreement with AstraZeneca (AZN) to evaluate casdatifan in combination with volrustomig for the treatment of clear cell renal cell carcinoma or ccRCC ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...

Leerink Partners analyst Daina Graybosch has maintained their bullish stance on RCUS stock, giving a Buy rating on September 16. Daina ...

Arcus Biosciences develops late-stage immunotherapies, with Domvanalimab and Casdatifan leading the way. See why I rate RCUS ...

As millions celebrate Labor Day, unions across Minnesota have seen some gains, with several groups recently settling contract talks which included pay increases and better benefits. Hamline ...

While Democratic nominee and Vice President Kamala Harris and Republican nominee and former President Donald Trump enter the home stretch of the presidential campaign, the outcome may very well be ...